Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer - Modern Pathology
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research
Pathology Outlines - CDX2
Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas - Modern Pathology
CDX2 (a, b) MUC2 (c, d) immunostaining patterns: a strong nuclear CDX2... | Download Scientific Diagram
Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer - Weimin Xu, Yilian Zhu, Wei Shen, Wenjun Ding, Tingyu Wu, Yuegui Guo, Xiaobing Chen, Mingxia Zhou, Yingwei Chen,
Diagnostics | Free Full-Text | CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | Cellular Oncology
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts | British Journal of Cancer
CDX1 and CDX2 immunohistochemistry and image analysis at different... | Download Scientific Diagram
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - ScienceDirect
Pathology Outlines - CDX2
Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
Distribution of CDX2 expression in patients with colorectal cancer and... | Download Scientific Diagram
CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer - ScienceDirect
CDX2 Antibody - Biocare Medical
The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report | World Journal of Surgical Oncology | Full Text
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
CDX2 - an overview | ScienceDirect Topics
Current Oncology | Free Full-Text | Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
